Loyola receives Tellabs Foundation grant to help address needs of tiny patients in NICU

NewsGuard 100/100 Score

A recent $250,000 grant from the Tellabs Foundation of Naperville, Ill., will help address the needs of tiny patients in the Neonatal Intensive Care Unit (NICU) at Ronald McDonald® Children's Hospital at Loyola University Medical Center.

"Education, technology and health care are our funding priorities. Put that together with Loyola's outstanding reputation in neonatal care and it was a win/win to award this grant," said Meredith Hilt, executive director of the foundation.

A major portion of the Tellabs Foundation grant will be used to purchase specially designed Giraffe® Omnibeds at a cost of approximately $38,000 each. The remainder will fund the purchase of precise syringe pumps at a cost of $3,000 each.

The Omnibeds provide uniform radiant heat and humidity control that mimics the womb environment; an integrated scale for monitoring weight; a rotating mattress; four portholes that facilitate care while maintaining temperature and humidity; an integrated X-ray cassette tray; and height controls to facilitate both care and nurturing. The syringe pumps allow a large filled syringe to be fitted into a pump, which can deliver smooth, accurate infusions of less than 0.5 mL (one-tenth of a teaspoon) per hour if needed.

"One of our greatest challenges in caring for preemies is the need for specialized equipment like this," said Marc Weiss, MD, the NICU's medical director. "It might seem obvious, but even many medical professionals don't stop to think about how the patient's size affects everything. Standard issue equipment just doesn't work for a child who weighs 9.2 ounces."

With the vision of benefactors like Tellabs Foundation, Loyola plans to continue its record of exemplary care for some of the Chicago area's tiniest patients.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prenatal cannabis use disorder linked to increased risk of neurodevelopmental disorders in offspring